There is evidence that chemerin may enhance the expression of various inflammatory factors, such as IL-6, TNFα, and CRP, resulting in blood vessel wall inflammation, increased monocyte attachment to endothelial cells, and endothelial dysfunction. Here, IL6 is linked to endothelial dysfunction.